Tech-Enabled Oncology Care Startup Thyme Care Raises $22M
Thyme Care, a technology-enabled oncology care management startup, has received $22 million in funding to expand its partnerships with oncologists, health plans, employers, and risk-based entities.
Nashville-based Thyme Care was founded by oncology industry veterans and clinicians. Robin Shah, Thyme Care's CEO and founder, previously worked at Flatiron Health and OneOncology.
The Thyme Care team said it is building navigation services that combine human-first support and an extensive oncology network enabled by scalable, intuitive technology. The company noted that navigation solutions often rely on limited technology without interaction with those who are actually delivering the care, leading to low engagement and utility at critical points of decision-making. “Thyme Care guides better oncology outcomes by engaging individuals and families in their health and informing their decisions at every stage of care. The company’s platform connects patients, caregivers, providers, and payers for integrated cancer care that leads to better results, higher value, and aligned incentives,” the company said.
"As someone who has spent 15 years working in oncology, I’m shocked at the difference in the patient experience between a person that has a friend or family member working in oncology and someone who is left to figure it out on their own. An insider can make the difference," said Shah in a statement. "Everyone deserves to have the best access to care and our health shouldn't be determined by the personal relationships we have. We created Thyme Care to be that insider and patient companion from the start, and a knowledgeable support system throughout the entire cancer journey, for everyone."
The funding round was led by Andreessen Horowitz, AlleyCorp, and Frist Cressey Ventures with participation from Casdin Capital and Bessemer.
"The entire Thyme Care team is rooted in deep clinical expertise, and is committed to using data and technology to impact clinical care," said Vineeta Agarwala, M.D., Ph.D., general partner at Andreessen Horowitz, in a statement. "Many of us have seen first-hand the gaps and disparities that exist in how patients access and receive cancer care today. Thyme Care’s platform provides the much-needed connective tissue between patients, payers, primary care providers, and specialized oncology care teams -- so that everyone has the information, collaboration tools, and care management resources needed to serve patients best."
In September, Thyme announced a partnership with Clover Health that builds on the companies’ shared vision to improve lives and eliminate health disparities by delivering personalized support and resources at no cost to Clover’s Medicare Advantage members across New Jersey.
Thyme Care’s board of directors includes:
- Vineeta Agarwala, M.D., Ph.D., General Partner at Andreessen Horowitz
- Brenton Fargnoli, M.D., Managing Partner of AlleyCorp Healthcare Fund
- Senator Bill Frist, M.D., Co-Founder and Partner of Frist Cressey Ventures (Board Observer)
- Bobby Green, M.D., President and Chief Medical Officer of Thyme Care
- Vivek Garipalli, CEO and Co-Founder of Clover Health
- Puneet Singh, CEO of Quartet Health
- Robin Shah, Founder and CEO of Thyme Care
